Clinical trials
Ischemic Stroke trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 10 |
| Terminated | 6 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 7 |
| H. Lundbeck A/S | 3 |
| Abbott Medical Devices | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| Leiden University | 2 |
| St. Antonius Hospital | 2 |
| UMC Utrecht | 2 |
| Bayer | 1 |
| CSL Behring | 1 |
| D-Pharm Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 40 |
| Stroke | 14 |
| Cardiovascular Diseases | 6 |
| Thrombosis | 6 |
| Atrial Fibrillation | 5 |
| Brain Infarction | 4 |
| Coronary Artery Disease | 4 |
| Myocardial Infarction | 4 |
| Carotid Stenosis | 3 |
| Cerebrovascular Disorders | 3 |
Trials
Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.